ONCOVISTA INNOVATIVE THERAPIES INC's ticker is and the CUSIP is 68232J105. A total of 2 filers reported holding ONCOVISTA INNOVATIVE THERAPIES INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,000 | -60.0% | 77,600 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $5,000 | +150.0% | 77,600 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | 0.0% | 77,600 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | +100.0% | 77,600 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 77,600 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 77,600 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 77,600 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -83.3% | 77,600 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $6,000 | +100.0% | 77,600 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | 0.0% | 77,600 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | -75.0% | 77,600 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $12,000 | -72.1% | 77,600 | 0.0% | 0.00% | -77.8% |
| Q3 2015 | $43,000 | -27.1% | 77,600 | -3.0% | 0.01% | -25.0% |
| Q2 2015 | $59,000 | +63.9% | 80,000 | 0.0% | 0.01% | +71.4% |
| Q1 2015 | $36,000 | +620.0% | 80,000 | 0.0% | 0.01% | +600.0% |
| Q4 2014 | $5,000 | -73.7% | 80,000 | 0.0% | 0.00% | -75.0% |
| Q3 2014 | $19,000 | -26.9% | 80,000 | 0.0% | 0.00% | -20.0% |
| Q2 2014 | $26,000 | +136.4% | 80,000 | 0.0% | 0.01% | +150.0% |
| Q1 2014 | $11,000 | +175.0% | 80,000 | 0.0% | 0.00% | +100.0% |
| Q4 2013 | $4,000 | -63.6% | 80,000 | 0.0% | 0.00% | -66.7% |
| Q3 2013 | $11,000 | +83.3% | 80,000 | 0.0% | 0.00% | +50.0% |
| Q2 2013 | $6,000 | – | 80,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Osborn Williams & Donohoe LLC | 77,600 | $12,000 | 0.00% |
| SIMMONS FIRST TRUST CO NA | 10,000 | $2,000 | 0.00% |